A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease

Clinical trial NCT06307613 · TERMINATED

Trial details

NCT number: NCT06307613
Sponsor: argenx
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Thyroid Eye Disease

Start date: 2024-03-27
Primary completion: 2025-12-15
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.